James M. Frates

Jim Frates is a highly experienced professional who currently holds the position of Chief Financial Officer at Amylyx Pharmaceuticals since January 2021. Prior to this role, they served as the CFO at Alkermes from July 1998 to January 2021. They also held a Vice President role at Robertson Stephens from July 1992 to June 1998, focusing on Biotechnology Investment Banking. Their educational background includes a Bachelor's degree in Political Science and Government from Harvard University and an MBA from Harvard Business School.